Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.

@article{Zisook2011EffectOA,
  title={Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.},
  author={S. Zisook and I. Lesser and B. Lebowitz and A. Rush and G. Kallenberg and S. Wisniewski and A. Nierenberg and M. Fava and J. Luther and D. Morris and M. Trivedi},
  journal={The Journal of clinical psychiatry},
  year={2011},
  volume={72 10},
  pages={
          1322-32
        }
}
OBJECTIVE To explore relationships between baseline sociodemographic and clinical features and baseline suicidal ideation, and treatment effects on suicidal ideation and behavior, in depressed outpatients. METHOD From March 2008 to September 2009, the Combining Medications to Enhance Depression Outcomes study, a single-blind, 7-month randomized trial, enrolled outpatients with nonpsychotic chronic and/or recurrent major depressive disorder (DSM-IV-TR criteria) in primary and psychiatric care… Expand

Paper Mentions

Interventional Clinical Trial
This study will compare whether a combination of antidepressant medications is better than one antidepressant medication alone when given as initial treatment for people with chronic… Expand
ConditionsMajor Depressive Disorder
InterventionDrug
Determinants and escitalopram treatment effects on suicidal ideation in patients with acute coronary syndrome: Findings from the K-DEPACS and EsDEPACS studies.
TLDR
Suicidal ideation is associated with unfavorable psychiatric and ACS status during the acute phase of ACS, and successful treatment of depression and anxiety with escitalopram had significant beneficial effects on suicidal ideation in these patients. Expand
Persistence and resolution of suicidal ideation during treatment of depression in patients with significant suicidality at the beginning of treatment: the CRESCEND study.
TLDR
Close monitoring for suicidal ideation may be needed beyond the initial weeks of treatment and even after a response to antidepressants is observed. Expand
Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder.
TLDR
Anxiety at baseline needs to be carefully evaluated in assessing suicide risk of patients withMDD in order to elucidate factors associated with emergence or persistence of suicidal ideation 6 months after initiation of outpatient treatment in patients with MDD. Expand
The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients
TLDR
These results confirm the reliability, validity, and applicability of the CHRT-SR12 to a placebo-controlled clinical trial of depressed outpatients receiving antidepressant medication. Expand
What the new US FDA guidance in assessing suicidal ideation and behavior in clinical trials means for trial design
TLDR
Monitoring of SIB is included in “all clinical trials involving any drug being developed for any psychiatric indication, as well as for all antiepileptic drugs and other neurologic drugs with central nervous system (CNS) activity, both inpatient and outpatient, including multiple-dose Phase 1 trials involving healthy volunteers”. Expand
Differential Associations of the Number of Comorbid Conditions and the Severity of Depression and Anxiety with Self-Reported Suicidal Ideation and Attempt in Major Depressive Disorder and Bipolar Disorder
Background: Previous studies have shown that the number of comorbidity, depression and anxiety severity were associated with increased risk for suicidal behaviors. This study was to investigate theExpand
Role of depression severity and impulsivity in the relationship between hopelessness and suicidal ideation in patients with major depressive disorder.
TLDR
Depressed patients with higher impulsivity appear to be more likely to have suicidal ideations even when they are less depressed, highlighting the importance of impulsivity assessment and alleviation of depressive symptoms to prevent suicidality in patients with MDD. Expand
Method of assessment determines prevalence of suicidal ideation among patients with depression
TLDR
Which MDD patient is classified as having suicidal ideation depends strongly on the method of assessment, with the greatest variation likely in primary care. Expand
A longitudinal investigation of the Concise Health Risk Tracking Self-Report (CHRT-SR) in suicidal patients during and after hospitalization
TLDR
The aims of this paper were to examine the construct validity and factor structure of the twelve- and seven-item versions of the Concise Health Risk Tracking Self-Report, and to test if clinically expected within-person changes in suicide risk over time were measurable using the CHRT-SR. Expand
Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)
TLDR
Even mild/moderate suicidality is associated with a failure of achieving treatment response, so adequate recognition of this condition should be ensured in the clinical practice. Expand
...
1
2
3
4
...